Tipsheet
What matters at India’s listed companies
Earnings · Chemicals · Mid cap

Jubilant Ingrevia's call transcript quantifies a ₹3,500 cr CDMO pipeline

The verbatim Q4/FY26 call transcript provides the peak-revenue estimate for over 100 CDMO opportunities and details a hedge against customer stress.

4 earlier stories on Jubilant Ingrevia Ltd.
Mkt cap₹9,902 cr
P/E35.63×
ROE8.58%
Debt / eq.0.26
Div yld0.40%
₹3,500 cr Estimated peak revenue from a pipeline of over 100 CDMO opportunities.

What's new

  • The company's CDMO pipeline holds over 100 opportunities with an estimated peak revenue of ₹3,500 cr.
  • The Bharuch CDMO plant has been successfully commissioned.
  • Contractual 'make-whole' provisions protect the company from financial stress at a major agro-CDMO customer.

Why this matters

The transcript adds a concrete number to a growth story, putting a scale on the CDMO push. The make-whole provision is a specific contractual hedge against a known risk, limiting downside on a key contract.

What we're watching

  • Conversion rate of the 100+ pipeline opportunities into firm contracts.
  • Margin recovery in the acetyls segment.
  • Execution progress at the new Bharuch plant.

The full read

Jubilant Ingrevia's Q4/FY26 earnings call transcript puts a number on its CDMO push. Management disclosed a pipeline of over 100 CDMO opportunities with an estimated peak revenue of ₹3,500 crore. The call also confirmed the successful commissioning of its Bharuch CDMO plant and detailed contractual 'make-whole' provisions that shield the company from financial stress at a major agro-CDMO customer. The document is fundamentally backward-looking, providing qualitative detail on the results already reported. The key new figure is the ₹3,500 crore pipeline estimate, which gives a concrete scale to the company's contract-development business.

Questions answered

What is the scale of Jubilant Ingrevia's CDMO opportunity pipeline?
The pipeline contains over 100 opportunities with an estimated peak revenue potential of ₹3,500 crore, as detailed in the Q4/FY26 earnings call transcript.
How does the company protect itself from the financial stress of a major customer?
The company has contractual 'make-whole' provisions that protect it against financial stress experienced by a major agro-CDMO customer, as discussed on the call.
What new operational capacity has been added?
The Bharuch CDMO plant has been successfully commissioned, according to the earnings call transcript.
Is this transcript new information for the market?
No. The document is the verbatim transcript of the previously held Q4/FY26 earnings conference call, providing qualitative detail on the already-announced results.
Mentioned: Jubilant Ingrevia · Bharuch CDMO plant · agro-CDMO customer
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Jubilant Ingrevia Ltd.

Chemicals
₹10,194 cr
P/E 36.68×

Latest quarter · Mar 2026

Sales₹1,179 cr
Net profit₹86 cr
Op. margin+13.8%
EPS₹5.48

Strength & growth

Debt / equity0.26×
Current ratio1.32×
  1. 29 May 2026 · 8:11 PM IST Jubilant Ingrevia's call transcript quantifies a ₹3,500 cr CDMO pipeline
  2. 41d ago Jubilant Ingrevia's $300M agro client faces financial distress
  3. 41d ago Jubilant Ingrevia posts highest profit in 14 quarters on volume recovery
  4. 41d ago Jubilant Ingrevia hits 14-quarter revenue high, guides for more
  5. 41d ago Jubilant Ingrevia's FY26 profit grows 10.6%. The numbers were expected.